Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1643489-24-0
2. (rac)-tavapadon
3. Tavapadon [usan]
4. Pf-06649751
5. Pt4p8mjp8l
6. Cvl-751
7. Tavapadon (usan)
8. 1,5-dimethyl-6-[2-methyl-4-[3-(trifluoromethyl)pyridin-2-yl]oxyphenyl]pyrimidine-2,4-dione
9. 1,5-dimethyl-6-[2-methyl-4-[3-(trifluoromethyl)pyridin-2-yl]oxy-phenyl]pyrimidine-2,4-dione
10. 2,4(1h,3h)-pyrimidinedione, 1,5-dimethyl-6-(2-methyl-4-((3-(trifluoromethyl)-2-pyridinyl)oxy)phenyl)-, (-)-
11. Tavapadon [inn]
12. Unii-pt4p8mjp8l
13. Chembl3697617
14. Schembl16334991
15. Dtxsid301337071
16. Bcp32804
17. Ex-a3416
18. Db14899
19. Hy-119486a
20. Ac-36997
21. Cs-0131271
22. D11431
23. (-)-1,5-dimethyl-6-(2-methyl-4-((3-(trifluoromethyl)-2-pyridinyl)oxy)phenyl)-2,4(1h,3h)-pyrimidinedione
24. (-)-1,5-dimethyl-6-(2-methyl-4-((3-(trifluoromethyl)pyridin-2-yl)oxy)phenyl)-2,4(1h,3h)-pyrimidinedione
25. (-)-1,5-dimethyl-6-(2-methyl-4-((3-(trifluoromethyl)pyridin-2-yl)oxy)phenyl)pyrimidine-2,4(1h,3h)-dione
26. 1,5-dimethyl-6-(2-methyl-4-((3-(trifluoromethyl)pyridin-2-yl)oxy)phenyl)pyrimidine-2,4(1h,3h)-dione
27. 86w
28. Pf-06649751;pf 06649751;pf-6649751;pf-06649751;pf06649751;pf 06649751
| Molecular Weight | 391.3 g/mol |
|---|---|
| Molecular Formula | C19H16F3N3O3 |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 3 |
| Exact Mass | 391.11437587 g/mol |
| Monoisotopic Mass | 391.11437587 g/mol |
| Topological Polar Surface Area | 71.5 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 665 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of Parkinson's disease
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Tavapadon manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tavapadon, including repackagers and relabelers. The FDA regulates Tavapadon manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tavapadon API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tavapadon supplier is an individual or a company that provides Tavapadon active pharmaceutical ingredient (API) or Tavapadon finished formulations upon request. The Tavapadon suppliers may include Tavapadon API manufacturers, exporters, distributors and traders.
Tavapadon Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tavapadon GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tavapadon GMP manufacturer or Tavapadon GMP API supplier for your needs.
A Tavapadon CoA (Certificate of Analysis) is a formal document that attests to Tavapadon's compliance with Tavapadon specifications and serves as a tool for batch-level quality control.
Tavapadon CoA mostly includes findings from lab analyses of a specific batch. For each Tavapadon CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tavapadon may be tested according to a variety of international standards, such as European Pharmacopoeia (Tavapadon EP), Tavapadon JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tavapadon USP).
LOOKING FOR A SUPPLIER?
